Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Macrophages in Osteosarcoma Immune Microenvironment: Implications for Immunotherapy
Zhong‐Wei Luo, Panpan Liu, Zhen‐Xing Wang, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Extracellular Vesicles from Akkermansia muciniphila Elicit Antitumor Immunity Against Prostate Cancer via Modulation of CD8+ T Cells and Macrophages
Zhong‐Wei Luo, Kun Xia, Yi-Wei Liu, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 2949-2963
Open Access | Times Cited: 107
Advances on immunotherapy for osteosarcoma
Shengnan Yu, Xudong Yao
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 40
Cell Membrane-Coated Biomimetic Nanoparticles in Cancer Treatment
Shu Zhang, Xiaojuan Zhang, Huan Gao, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 531-531
Open Access | Times Cited: 18
Macrophage membrane-coated nanovesicles for dual-targeted drug delivery to inhibit tumor and induce macrophage polarization
Xin Huang, Lutong Wang, Haoyu Guo, et al.
Bioactive Materials (2022) Vol. 23, pp. 69-79
Open Access | Times Cited: 64
Expression of Lipid-Metabolism Genes Is Correlated With Immune Microenvironment and Predicts Prognosis in Osteosarcoma
Hu Qian, Ting Lei, Yihe Hu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 59
Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks
Anthony R. Cillo, Elina Mukherjee, Nathanael G. Bailey, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 22, pp. 4968-4982
Open Access | Times Cited: 45
An overview of resistance to chemotherapy in osteosarcoma and future perspectives
Dorian Yarih García-Ortega, Sara Aileen Cabrera-Nieto, Haydee Sarai Caro-Sánchez, et al.
Cancer Drug Resistance (2022) Vol. 5, Iss. 2, pp. 762-93
Open Access | Times Cited: 42
The combination of eddy thermal effect of biodegradable magnesium with immune checkpoint blockade shows enhanced efficacy against osteosarcoma
Jun Ge, Nailin Yang, Yuqi Yang, et al.
Bioactive Materials (2023) Vol. 25, pp. 73-85
Open Access | Times Cited: 27
Tumor-associated macrophages induce inflammation and drug resistance in a mechanically tunable engineered model of osteosarcoma
Letitia K. Chim, Isabelle L. Williams, Caleb J. Bashor, et al.
Biomaterials (2023) Vol. 296, pp. 122076-122076
Closed Access | Times Cited: 24
Single-cell RNA sequencing reveals the cellular and molecular heterogeneity of treatment-naïve primary osteosarcoma in dogs
Dylan T. Ammons, Leone S. Hopkins, Kathryn E. Cronise, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 10
Mesenchymal Stem Cells and Extracellular Vesicles in Osteosarcoma Pathogenesis and Therapy
Virinder Kaur Sarhadi, Ravindra Daddali, Riitta Seppänen‐Kaijansinkko
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11035-11035
Open Access | Times Cited: 50
Upregulation of THBS1 is Related to Immunity and Chemotherapy Resistance in Gastric Cancer
Xiuyuan Zhang, Tingting Huang, Yiming Li, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 4945-4957
Open Access | Times Cited: 46
Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality
Lei Yu, Jian Zhang, Yunfeng Li
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
Transcriptional profiling of canine osteosarcoma identifies prognostic gene expression signatures with translational value for humans
Joshua Mannheimer, Gregory J. Tawa, David Gerhold, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 17
Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis
Bikesh K. Nirala, Taku Yamamichi, D. Isabel Petrescu, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5108-5108
Open Access | Times Cited: 17
A novel small-molecule antagonist enhances the sensitivity of osteosarcoma to cabozantinib in vitro and in vivo by targeting DNMT-1 correlated with disease severity in human patients
Ji‐Hai Wang, Zhen Zeng, Jie Sun, et al.
Pharmacological Research (2021) Vol. 173, pp. 105869-105869
Closed Access | Times Cited: 33
Tumor-associated macrophages: Prognostic and therapeutic targets for cancer in humans and dogs
Rachel V. Brady, Douglas H. Thamm
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Advanced nanoscale drug delivery systems for bone cancer therapy
Nazanin Amiryaghoubi, Marziyeh Fathi, Jaleh Barar, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 6, pp. 166739-166739
Closed Access | Times Cited: 14
MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophages in osteosarcoma
Bikesh K. Nirala, Tajhal D. Patel, Lyazat Kurenbekova, et al.
JCI Insight (2023) Vol. 8, Iss. 13
Open Access | Times Cited: 14
Osteosarcoma in Children: Not Only Chemotherapy
Maura Argenziano, Chiara Tortora, Elvira Pota, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 923-923
Open Access | Times Cited: 30
Single-cell RNA-seq reveals intratumoral heterogeneity in osteosarcoma patients: A review
Dylan D. Thomas, Ryan A. Lacinski, Brock A. Lindsey
Journal of bone oncology (2023) Vol. 39, pp. 100475-100475
Open Access | Times Cited: 12
Aptamer-functionalized hydrogels promote bone healing by selectively recruiting endogenous bone marrow mesenchymal stem cells
Jiang-Shan Gong, Guo‐Qiang Zhu, Yu Zhang, et al.
Materials Today Bio (2023) Vol. 23, pp. 100854-100854
Open Access | Times Cited: 12
12 Survival-related differentially expressed genes based on the TARGET-osteosarcoma database
Emel Rothzerg, Jiake Xu, David Wood, et al.
Experimental Biology and Medicine (2021) Vol. 246, Iss. 19, pp. 2072-2081
Open Access | Times Cited: 26
Identification of M2 macrophage markers for predicting outcome and therapeutic response in osteosarcoma: Integrated analysis of single-cell and bulk RNA-sequencing
Yang Liu, Liwei Liu, Xianpeng Wei, et al.
Journal of Cancer (2025) Vol. 16, Iss. 6, pp. 1873-1887
Open Access
Activation of pyroptosis and immunogenic cell death by targeted liposomal cisplatin for enhanced chemo-immunotherapy for osteosarcoma
Jingyou Bi, Yuchen Han, Xin-Li Han, et al.
Nano Today (2025) Vol. 62, pp. 102717-102717
Closed Access
Page 1 - Next Page

Scroll to top